one hundred and eight patients with stage iii or iv epithelial ovarian cancers were randomly allocated to treatment with either melphalan or the combination of actinomycin-d , 5-fluorouracil , and cyclophosphamide ( acfucy ) .
C0016360
5-fluorouracil
C0050547
acfucy